Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?

Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?

Bibliographic Details
Main Author: Chan, Arlene
Format: Journal Article
Published: 2017
Online Access:http://hdl.handle.net/20.500.11937/58267

Internet

http://hdl.handle.net/20.500.11937/58267

Similar Items